Background Although voting is recognised as a social determinant of health, the association between electoral participation ...

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.

“Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers,” by Dewpoint Therapeutics. News release; Oct. 21, 2025. For more news on cancer ...

Long-acting injectables (LAIs) were designed to solve this problem by reducing the burden of daily pill-taking and ensuring more consistent drug exposure. Underutilization of LAIs in the U.S is common ...

The phase 2 PHAROS study previously showed that encorafenib plus binimetinib has antitumor activity in patients with BRAF V600E-mutant metastatic non-small cell lung cancer (mNSCLC). In PHAROS, 98 ...

The FDA has approved Kygevvi (doxecitine and doxribtimine) for the treatment of TK2d in adults and pediatric patients with an age of symptom onset on or before 12 years.

Akeso, Inc. (HKEX: 9926.HK) is excited to announce that the final Overall Survival (OS) analysis results from the HARMONi-A study, a Phase III study evaluating ivonescimab combined with chemotherapy ...

Scientists found a new sea anemone species off Japan's coast. This anemone, named Paracalliactis tsukisome, builds shell-like ...

Altcoin traders use 8-step plan to manage risk, with 72% of top coins down 50%. Here are survival strategies for altcoin ...

Pretreatment eosinophilia in NSCLC patients is associated with increased immune-related adverse events and reduced progression-free survival when treated with ICIs. The review included 11 ...